Multiple Sclerosis Trial, By Invitation NCT07202780 Sponsor: Sanko University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, By Invitation

NCT07202780
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with multiple sclerosis (MS) using a specific set of recognised diagnostic guidelines, and who are being followed at the Neurology Outpatient Clinic of Sanko University Hospital.
  • People who are between 18 and 50 years of age.
  • People who have not had an MS attack or relapse in the past 6 months.
  • People whose MS-related disability is rated at a certain level or below on a standard scale used by neurologists (an EDSS score of 4.5 or lower — confirm with trial site if unsure what this means for your situation).
  • People who have given their consent to take part in the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had surgery on their legs or lower limbs within the past 12 months.
  • People who have received physiotherapy within the past 6 months.
  • People who currently have an injury or broken bone in their legs or lower limbs.
  • People who have another condition affecting their nerves, muscles, joints, or lungs, in addition to MS.
  • People who are unable to cooperate with the measurements and assessments required by the study.
  • People who have received high-dose steroid treatment (sometimes called pulse steroid therapy) or injections of botulinum toxin or phenol within the past 6 months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Sanko University
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
1 August 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Assessment of Neurological Disability Level:; Fatigue Severity Scale; The Hospital Anxiety and Depression Scale; myoton pro; Assessment of Lower Limb Functionality and Muscle Strength; Assessment of Respiratory Muscle Strength:; A Spirometry Test (SFT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov